Form 10-Q - Quarterly report [Sections 13 or 15(d)]

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Sutro Biopharma (NASDAQ:STRO)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Sutro Biopharma Charts.

Sutro Biopharma (NASDAQ:STRO)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Sutro Biopharma Charts.

Sutro Biopharma Inc News

Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Tuesday 7 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Sutro Biopharma and Boehringer Ingelheim BioXcellence™ collaboration: Established first-in-class cell-free capabilities at commercial scale
Tuesday 7 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 10 December 2024 (2 months ago) • Edgar (US Regulatory)

Sutro Biopharma Announces Selected Dose for Luvelta and Topline Results from Dose-Optimization Portion of REFRαME-O1 Trial in Platinum Resistant Ovarian Cancer
Tuesday 10 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 3 December 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference
Monday 4 November 2024 (3 months ago) • GlobeNewswire Inc.

Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML
Friday 1 November 2024 (3 months ago) • GlobeNewswire Inc.

More Sutro Biopharma Inc News Articles

MineralRite (PK)

NioCorp Developments

Bioelectronics (PK)

TheGlobe com (PK)

Kraig Biocraft Laborator... (QB)

Lightwave Logic

Elite Pharmaceuticals (QB)

Intergrated Cannabis Sol... (PK)

North Bay Resources (PK)

Fannie Mae (QB)

Rennova Health (CE)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions